Oxford BioMedica Share Price (OXB)

4.18 +0.12 (+2.96%) delayed: 9:58PM GMT
Bid price 4.05 Open price 4.43
Ask price 4.30 Prev close 4.22
High price 4.43 Spread 5.81%
Low price 4.15 Volume 2,055,297

Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.

Oxford BioMedica Share Price Chart

Advanced Charts >>

Register now for FREE Oxford BioMedica share price charts

Oxford BioMedica Share Price Information

Name Oxford BioMedica Epic OXB
Sector Pharmaceuticals & Biotechnology ISIN GB0006648157
Activites Oxford BioMedica plc is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Index n/a

Oxford BioMedica Key Numbers

Latest Share Price (p) 4.18 Net Gearing (%) 60.95
Market Capitalisation (£m) 125.38 Gross Gearing (%) 78.99
Shares in issue (m) 3,088.05 Debt Ratio 71.84
P/E Ratio -7.96 Debt-to-Equity Ratio 0.68
Total dividends per share (p) 0.00 Assets / Equity Ratio 4.76
Dividend Yield (%) 0.00 Price to book value 11.51
Dividend cover (x) 0.00 ROCE (%) -43.90
Earning per share (p) -0.51 EPS Growth (%) -18.60
52 week high / low 7.75 / 2.57 DPS Growth (%) n/a

Oxford BioMedica Director Deals

Dec.Date Type Director Pos No. of Shares
20/12/2016 LOF Dr Lorenzo Tallarigo CH 65,993
06/12/2016 BUY Martin Diggle NED 833,000
05/12/2016 BUY Martin Diggle NED 4,082,333
28/11/2016 BUY Dr Lorenzo Tallarigo CH 75,417
25/10/2016 BUY Dr Lorenzo Tallarigo CH 77,864

More Oxford BioMedica Director Deals >>

Oxford BioMedica Company News

09:30 03/01/2017

Block Listing Return

RNS Number : 1753T Oxford Biomedica PLC 03 January 2017   For Immediate Release 3 January 2017   OXFORD BIOMEDICA PLC   BLOCK LISTING RETURN   Name of applicant : OXFORD BIOMEDICA PLC Name of scheme: 2015...

09:28 03/01/2017

Total Voting Rights

RNS Number : 1745T Oxford Biomedica PLC 03 January 2017     Oxford BioMedica Total Voting Rights     Oxford, UK - 3 January 2017: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), announces that in accordance with the FCA's...

11:45 20/12/2016

Director Deals - Oxford BioMedica PLC (OXB)

Dr Lorenzo Tallarigo, Chairman, received in lieu of fees/salary 65,993 shares in the company on the 20th December 2016 at a price of 4.00p. The Director now holds 1,654,109 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

More Oxford BioMedica Company News >>

Register now for FREE Oxford BioMedica company news

Oxford BioMedica Share Price Discussions

11 months ago

CANCER drug co. Oxford Biomedica charts (OXB)

OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one. http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

more than 1 year ago

OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)

Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!

more than 1 year ago

OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)

Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!

Register now for FREE Oxford BioMedica share price discussions